BMRN vs. AVGO
BMRN (BioMarin Pharmaceutical Inc.) and AVGO (Broadcom Inc.) are both stocks. BMRN operates in Biotechnology (Healthcare), while AVGO operates in Semiconductors (Technology). Over the past 10 years, BMRN returned -4.50%/yr vs 41.92%/yr for AVGO. At a 0.29 correlation, their price movements are largely independent.
Performance
BMRN vs. AVGO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BMRN achieves a -4.98% return, which is significantly lower than AVGO's 21.29% return. Over the past 10 years, BMRN has underperformed AVGO with an annualized return of -4.50%, while AVGO has yielded a comparatively higher 41.92% annualized return.
BMRN
- 1D
- 3.31%
- 1M
- 6.07%
- YTD
- -4.98%
- 6M
- 4.92%
- 1Y
- 0.64%
- 3Y*
- -14.93%
- 5Y*
- -6.23%
- 10Y*
- -4.50%
AVGO
- 1D
- -12.59%
- 1M
- -1.98%
- YTD
- 21.29%
- 6M
- 10.38%
- 1Y
- 61.75%
- 3Y*
- 75.80%
- 5Y*
- 57.68%
- 10Y*
- 41.92%
BMRN vs. AVGO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BMRN BioMarin Pharmaceutical Inc. | -4.98% | -9.58% | -31.83% | -6.83% | 17.14% | 0.75% | 3.71% | -0.70% | -4.51% | 7.64% |
AVGO Broadcom Inc. | 21.29% | 50.63% | 110.49% | 104.18% | -13.27% | 56.48% | 44.88% | 29.05% | 2.18% | 48.19% |
Correlation
The correlation between BMRN and AVGO is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Aug 7, 2009 | 0.29 |
The correlation between BMRN and AVGO shifts across timeframes, from -0.01 (1 year) to 0.29 (all time), reflecting how their relationship changes across market environments.
Fundamentals
BMRN:
$11.16B
AVGO:
$2.04T
BMRN:
$1.37
AVGO:
$6.01
BMRN:
41.17
AVGO:
69.71
BMRN:
2.47
AVGO:
0.87
BMRN:
3.41
AVGO:
27.08
BMRN:
1.80
AVGO:
23.29
BMRN:
$3.24B
AVGO:
$75.47B
BMRN:
$2.46B
AVGO:
$50.53B
BMRN:
$439.56M
AVGO:
$41.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BMRN vs. AVGO — Risk / Return Rank
BMRN
AVGO
BMRN vs. AVGO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BioMarin Pharmaceutical Inc. (BMRN) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BMRN | AVGO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.37 | ||
| Sortino ratioReturn per unit of downside risk | -1.66 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 1.26 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | 0.03 | 2.17 | -2.14 |
| Martin ratioReturn relative to average drawdown | 0.06 | 5.19 | -5.13 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BMRN | AVGO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.02 | 1.39 | -1.37 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.19 | 1.34 | -1.53 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.13 | 1.07 | -1.20 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.11 | 1.10 | -0.99 |
Drawdowns
BMRN vs. AVGO - Drawdown Comparison
The maximum BMRN drawdown since its inception was -90.58%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for BMRN and AVGO.
Loading charts...
Drawdown Indicators
| BMRN | AVGO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.58% | -48.30% | -42.28% |
Max Drawdown (1Y)Largest decline over 1 year | -22.49% | -28.67% | +6.18% |
Max Drawdown (3Y)Largest decline over 3 years | -49.83% | -41.15% | -8.68% |
Max Drawdown (5Y)Largest decline over 5 years | -57.64% | -41.15% | -16.49% |
Max Drawdown (10Y)Largest decline over 10 years | -62.09% | -48.30% | -13.79% |
Current DrawdownCurrent decline from peak | -62.13% | -13.01% | -49.12% |
Average DrawdownAverage peak-to-trough decline | -45.51% | -7.97% | -37.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.86% | 11.94% | -1.08% |
Volatility
BMRN vs. AVGO - Volatility Comparison
The current volatility for BioMarin Pharmaceutical Inc. (BMRN) is 15.03%, while Broadcom Inc. (AVGO) has a volatility of 18.29%. This indicates that BMRN experiences smaller price fluctuations and is considered to be less risky than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BMRN | AVGO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.03% | 18.29% | -3.26% |
Volatility (6M)Calculated over the trailing 6-month period | 27.90% | 33.56% | -5.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 34.72% | 44.74% | -10.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.90% | 43.15% | -10.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.52% | 39.38% | -3.86% |
Dividends
BMRN vs. AVGO - Dividend Comparison
BMRN has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.59%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AVGO Broadcom Inc. | 0.59% | 0.70% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% |
BMRN BioMarin Pharmaceutical Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
BMRN vs. AVGO - Financials Comparison
This section allows you to compare key financial metrics between BioMarin Pharmaceutical Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BMRN vs. AVGO - Profitability Comparison
BMRN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BioMarin Pharmaceutical Inc. reported a gross profit of 571.21M and revenue of 766.21M. Therefore, the gross margin over that period was 74.6%.
AVGO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported a gross profit of 14.92B and revenue of 22.19B. Therefore, the gross margin over that period was 67.2%.
BMRN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BioMarin Pharmaceutical Inc. reported an operating income of 129.64M and revenue of 766.21M, resulting in an operating margin of 16.9%.
AVGO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported an operating income of 10.87B and revenue of 22.19B, resulting in an operating margin of 49.0%.
BMRN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BioMarin Pharmaceutical Inc. reported a net income of 105.53M and revenue of 766.21M, resulting in a net margin of 13.8%.
AVGO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported a net income of 9.31B and revenue of 22.19B, resulting in a net margin of 42.0%.
Frequently Asked Questions
BMRN and AVGO have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVGO has higher volatility (18.29%) compared to BMRN (15.03%). In terms of maximum drawdown, BMRN dropped -90.58% vs AVGO's -48.30%.
AVGO currently has the higher Sharpe Ratio (1.39 vs 0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BMRN and AVGO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer